Picture loading failed.

Anti-IGHE therapeutic antibody (Pre-made Omalizumab biosimilar,Whole mAb) is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).

Omalizumab, sold under the brand name Xolair, is a medication used to treat asthma, nasal polyps, and urticaria.

Order informatioin


Delivery impact due to the Coronavirus Outbreak

With the COVID-19 outbreak in the world, many flights have been cancelled. In order for the customer to receive the goods properly, we use the FedEx Customized Freight (FCF) of Fedex which demands a higher fee. If the delivery fee is more expensive in your area, we will contact you by mail.

Catalog No. Package Price(In USD) Qty (Quantity) Sum(In USD)
GMP-Bios-ab-398-1mg 1mg 3090
GMP-Bios-ab-398-10mg 10mg 21890
GMP-Bios-ab-398-100mg 100mg 148000
GMP-Bios-ab-398-xmg >100mg Inquiry
Shipping Cost: 760.00
Total:



Description

Products Name (INN Index) Anti-IGHE therapeutic antibody (Pre-made Omalizumab biosimilar,Whole mAb)
INN Name Omalizumab
TargetIGHE
FormatWhole mAb
Derivation
Species ReactivityHuman
CH1 IsotypeIgG1
VD LCKappa
Highest_Clin_Trial (Jan '20)Approved
Est. StatusActive
100% SI Structure4x7s:HL/2xa8:HL/4x7t:HL:AB/5hys:HL:AB:EF:CD/6tcm:HL/6tcn:HL/6tco:BA/6tcp:HL
99% SI Structure5g64:IM:HL
95-98% SI StructureNone
Year Proposed2000
Year Recommended2001
CompaniesDana-Farber Cancer Institute;Genentech;John Hopkins University;Novartis
Conditions ApprovedAllergic asthma;Urticaria
Conditions ActiveSeasonal allergic rhinitis;Nasal polyps;Mastocytosis;Asthma;Nephritis
Conditions DiscontinuedHypersensitivity;Peanut hypersensitivity
Development Techna